Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma

(2009) X.-F. Cao et al.   DISEASES OF THE ESOPHAGUS

Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma

(2009) Jin Lv et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Neoadjuvant chemoradiotherapy for resectable esophagealcarcinoma: A meta-analysis

(2009) Hai-Lin Jin et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY